July 16, 2012 – San Diego and Tarrytown, New York. – Afraxis and PsychoGenics today announced an alliance to offer Afraxis’ Enhanced Spine Platform (ESP) technology as part of PsychoGenics’ comprehensive testing capabilities and drug discovery services.
